InnoSIGN is a manufacturer of precision medicine for diagnostics and drug development applications.
InnoSIGN has raised $8.1M in total funding. The most recent round was Series A. The last funding was announced in March 2022.
InnoSIGN's investors include Casdin Capital, Thuja Capital, Brabant Development, Life Science Angels.
InnoSIGN is headquartered in Eindhoven, The Netherlands.
InnoSIGN is a manufacturer of precision medicine for diagnostics and drug development applications.
InnoSIGN is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"InnoSIGN — Funding & Investors." VCBacked, March 22, 2022, https://www.vcbacked.co/company/innosign. Accessed September 30, 2026.
VCBacked. (2022). InnoSIGN — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/innosign
{{cite web |title=InnoSIGN — Funding & Investors |url=https://www.vcbacked.co/company/innosign |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated